Global CNS Therapeutics Market Research Report 2016

September 2016 | 112 pages | ID: G337EA29E54EN
QYResearch

Abstracts

Notes:

Production, means the output of CNS Therapeutics

Revenue, means the sales value of CNS Therapeutics

This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer, Inc. (USA)
• Johnson & Johnson (USA)
• Bristol-Myers Squibb (USA)
• Dainippon Sumitomo Pharma Co., Ltd. (Japan)
• Eisai Co., Ltd. (Japan)
• Eli Lilly and Co. (USA)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Fabre-Kramer Pharmaceuticals, Inc. (USA)
• BIAL Group (Portugal)
• Boehringer Ingelheim GmbH (Germany)
• Sanofi S.A (France)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of CNS Therapeutics in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Anti-Alzheimer's Drugs
• Anti-Parkinson's Drugs
• Anti-Epilepsy Drugs
• Pain Management Drugs
• Anti-Psychotics Drugs

Split by application, this report focuses on consumption, market share and growth rate of CNS Therapeutics in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global CNS Therapeutics Market Research Report 2016

1 CNS THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of CNS Therapeutics
1.2 CNS Therapeutics Segment by Type
  1.2.1 Global Production Market Share of CNS Therapeutics by Type in 2015
  1.2.2 Anti-Alzheimer's Drugs
  1.2.3 Anti-Parkinson's Drugs
  1.2.4 Anti-Epilepsy Drugs
  1.2.5 Pain Management Drugs
  1.2.6 Anti-Psychotics Drugs
1.3 CNS Therapeutics Segment by Application
  1.3.1 CNS Therapeutics Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 CNS Therapeutics Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of CNS Therapeutics (2011-2021)

2 GLOBAL CNS THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global CNS Therapeutics Production and Share by Manufacturers (2015 and 2016)
2.2 Global CNS Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global CNS Therapeutics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers CNS Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 CNS Therapeutics Market Competitive Situation and Trends
  2.5.1 CNS Therapeutics Market Concentration Rate
  2.5.2 CNS Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL CNS THERAPEUTICS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global CNS Therapeutics Production and Market Share by Region (2011-2016)
3.2 Global CNS Therapeutics Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL CNS THERAPEUTICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global CNS Therapeutics Consumption by Regions (2011-2016)
4.2 North America CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL CNS THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global CNS Therapeutics Production and Market Share by Type (2011-2016)
5.2 Global CNS Therapeutics Revenue and Market Share by Type (2011-2016)
5.3 Global CNS Therapeutics Price by Type (2011-2016)
5.4 Global CNS Therapeutics Production Growth by Type (2011-2016)

6 GLOBAL CNS THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global CNS Therapeutics Consumption and Market Share by Application (2011-2016)
6.2 Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL CNS THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer, Inc. (USA)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 CNS Therapeutics Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Johnson & Johnson (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 CNS Therapeutics Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Johnson & Johnson (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bristol-Myers Squibb (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 CNS Therapeutics Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bristol-Myers Squibb (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Dainippon Sumitomo Pharma Co., Ltd. (Japan)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 CNS Therapeutics Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Eisai Co., Ltd. (Japan)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 CNS Therapeutics Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Eisai Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Eli Lilly and Co. (USA)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 CNS Therapeutics Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Eli Lilly and Co. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 F. Hoffmann-La Roche Ltd. (Switzerland)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 CNS Therapeutics Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Fabre-Kramer Pharmaceuticals, Inc. (USA)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 CNS Therapeutics Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 BIAL Group (Portugal)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 CNS Therapeutics Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 BIAL Group (Portugal) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Boehringer Ingelheim GmbH (Germany)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 CNS Therapeutics Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Sanofi S.A (France)

8 CNS THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 CNS Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of CNS Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 CNS Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of CNS Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CNS THERAPEUTICS MARKET FORECAST (2016-2021)

12.1 Global CNS Therapeutics Production, Revenue Forecast (2016-2021)
12.2 Global CNS Therapeutics Production, Consumption Forecast by Regions (2016-2021)
12.3 Global CNS Therapeutics Production Forecast by Type (2016-2021)
12.4 Global CNS Therapeutics Consumption Forecast by Application (2016-2021)
12.5 CNS Therapeutics Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of CNS Therapeutics
Figure Global Production Market Share of CNS Therapeutics by Type in 2015
Figure Product Picture of Anti-Alzheimer's Drugs
Table Major Manufacturers of Anti-Alzheimer's Drugs
Figure Product Picture of Anti-Parkinson's Drugs
Table Major Manufacturers of Anti-Parkinson's Drugs
Figure Product Picture of Anti-Epilepsy Drugs
Table Major Manufacturers of Anti-Epilepsy Drugs
Figure Product Picture of Pain Management Drugs
Table Major Manufacturers of Pain Management Drugs
Figure Product Picture of Anti-Psychotics Drugs
Table Major Manufacturers of Anti-Psychotics Drugs
Table CNS Therapeutics Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure China CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure India CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global CNS Therapeutics Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global CNS Therapeutics Production of Key Manufacturers (2015 and 2016)
Table Global CNS Therapeutics Production Share by Manufacturers (2015 and 2016)
Figure 2015 CNS Therapeutics Production Share by Manufacturers
Figure 2016 CNS Therapeutics Production Share by Manufacturers
Table Global CNS Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global CNS Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global CNS Therapeutics Revenue Share by Manufacturers
Table 2016 Global CNS Therapeutics Revenue Share by Manufacturers
Table Global Market CNS Therapeutics Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market CNS Therapeutics Average Price of Key Manufacturers in 2015
Table Manufacturers CNS Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers CNS Therapeutics Product Type
Figure CNS Therapeutics Market Share of Top 3 Manufacturers
Figure CNS Therapeutics Market Share of Top 5 Manufacturers
Table Global CNS Therapeutics Production by Regions (2011-2016)
Figure Global CNS Therapeutics Production and Market Share by Regions (2011-2016)
Figure Global CNS Therapeutics Production Market Share by Regions (2011-2016)
Figure 2015 Global CNS Therapeutics Production Market Share by Regions
Table Global CNS Therapeutics Revenue by Regions (2011-2016)
Table Global CNS Therapeutics Revenue Market Share by Regions (2011-2016)
Table 2015 Global CNS Therapeutics Revenue Market Share by Regions
Table Global CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table North America CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table China CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table India CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Table Global CNS Therapeutics Consumption Market by Regions (2011-2016)
Table Global CNS Therapeutics Consumption Market Share by Regions (2011-2016)
Figure Global CNS Therapeutics Consumption Market Share by Regions (2011-2016)
Figure 2015 Global CNS Therapeutics Consumption Market Share by Regions
Table North America CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Europe CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table China CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Japan CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table India CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
Table Global CNS Therapeutics Production by Type (2011-2016)
Table Global CNS Therapeutics Production Share by Type (2011-2016)
Figure Production Market Share of CNS Therapeutics by Type (2011-2016)
Figure 2015 Production Market Share of CNS Therapeutics by Type
Table Global CNS Therapeutics Revenue by Type (2011-2016)
Table Global CNS Therapeutics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of CNS Therapeutics by Type (2011-2016)
Figure 2015 Revenue Market Share of CNS Therapeutics by Type
Table Global CNS Therapeutics Price by Type (2011-2016)
Figure Global CNS Therapeutics Production Growth by Type (2011-2016)
Table Global CNS Therapeutics Consumption by Application (2011-2016)
Table Global CNS Therapeutics Consumption Market Share by Application (2011-2016)
Figure Global CNS Therapeutics Consumption Market Share by Application in 2015
Table Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
Figure Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (USA) CNS Therapeutics Market Share (2011-2016)
Table Johnson & Johnson (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson (USA) CNS Therapeutics Market Share (2011-2016)
Table Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb (USA) CNS Therapeutics Market Share (2011-2016)
Table Dainippon Sumitomo Pharma Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Market Share (2011-2016)
Table Eisai Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Co., Ltd. (Japan) CNS Therapeutics Market Share (2011-2016)
Table Eli Lilly and Co. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Co. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Co. (USA) CNS Therapeutics Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Market Share (2011-2016)
Table Fabre-Kramer Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Market Share (2011-2016)
Table BIAL Group (Portugal) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BIAL Group (Portugal) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure BIAL Group (Portugal) CNS Therapeutics Market Share (2011-2016)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of CNS Therapeutics
Figure Manufacturing Process Analysis of CNS Therapeutics
Figure CNS Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of CNS Therapeutics Major Manufacturers in 2015
Table Major Buyers of CNS Therapeutics
Table Distributors/Traders List
Figure Global CNS Therapeutics Production and Growth Rate Forecast (2016-2021)
Figure Global CNS Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Global CNS Therapeutics Production Forecast by Regions (2016-2021)
Table Global CNS Therapeutics Consumption Forecast by Regions (2016-2021)
Table Global CNS Therapeutics Production Forecast by Type (2016-2021)
Table Global CNS Therapeutics Consumption Forecast by Application (2016-2021)